Lights and Shadows of Bariatric Surgery: Insights from a Nationwide Administrative Database of People Living with Type 1 Diabetes and Obesity
The risks of severe hypoglycemia or ketoacidosis in patients with type 1 diabetes undergoing BS remains a real concern and emphasizes the importance of involving the diabetologist in the operative decision with joint follow-up with the nutritionist.
Authors
- Nicholas Shoung (ORCID: https://orcid.org/0000-0002-1780-1627)
- Aurélie Phan
- Sébastien Czernichow (ORCID: https://orcid.org/0000-0001-7353-2532)
- Anne Dutour (ORCID: https://orcid.org/0000-0002-5844-5884)
- B. Detournay (ORCID: https://orcid.org/0000-0001-7843-4608)
- E. Torreton
- Claire Rives‐Lange (ORCID: https://orcid.org/0000-0001-5393-5406)
- Claire Carette (ORCID: https://orcid.org/0000-0002-8175-0369)
Institutions
- Inserm (FR)
- Université Paris Cité (FR)
- Aix-Marseille Université (FR)
- Assistance Publique Hôpitaux de Marseille (FR)
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
- Cemka-Eval (France) (FR)
- Sorbonne Paris Cité (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Européen Georges-Pompidou (FR)
- Centre de Recherche sur l'Inflammation (FR)
- Unité de recherche sur les maladies cardiovasculaires et métaboliques (FR)
Publication Details
- Journal
- Diabetes Therapy
- Published
- 2025-04-11
- DOI
- https://doi.org/10.1007/s13300-025-01709-8
- Citations
- 1
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Nestlé Health Science
- Novo Nordisk
- Ipsen